Serotonin, obsessive compulsive disorder and the basal ganglia

References

• Alexander G.E., DeLong M.R., Strick P.C. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 1986; 9: 359–381
   Google Scholar
• Altshuler L.L., Conrad A., Kovelman J.A., Scheibel A. Hippocampal pyramidal cell orientation in schizophrenia. Archives of General Psychiatry 1987; 44: 1094–1098
   PubMedGoogle Scholar
• Aosaki T., Tsubokawa H., Ishida A., Watanabe K., Graybiel A.M., Kimura M. Responses of tonically active neurons in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning. Journal of Neuroscience 1994; 14(6)3969–3984
   PubMed Web of Science ®Google Scholar
• Barr L.C., Goodman W.K., McDougle C.J., Delgado P.L., Heninger G.R., Charney D.S., Price L.H. Tryptophan depletion in patients with obsessive-compulsive disorder who respond to serotonin reuptake inhibitors. Archives of General Psychiatry 1994; 51: 309–317
   PubMed Web of Science ®Google Scholar
• Baxter L.R., Phelps M.E., Mazziotta J.C., Guze B.H., Schwartz J.M., Selin C.E. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and normal controls. Archives of General Psychiatry 1987; 44: 211–218
   PubMed Web of Science ®Google Scholar
• Baxter L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., Akazraju A., Selin C.E., Ferng H.-K., Munford P., Phelps M.E. Caudate glocose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry 1992; 49: 681–689
   PubMed Web of Science ®Google Scholar
• Baxter L. R., Jr., Schwartz J.M., Mazziotta J.C., et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. American Journal of Psychiatry 1988; 145: 12
   Google Scholar
• Benkelfat C., Nordahl T.E., Semple W.E., et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Archives of General Psychiatry 1990; 47: 840–848
   PubMed Web of Science ®Google Scholar
• Blier P., de Montigney C. Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1987; 1: 470–480
   PubMed Web of Science ®Google Scholar
• Bogerts B., Meertz E., Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia: A morphometric study of brain volume and shrinkage. Archives of General Psychiatry 1985; 42: 784–791
   PubMed Web of Science ®Google Scholar
• Brashers-Krug T., Graybiel A.M. Dopamine-rich striosomes in the sensorimotor striatum. Society for Neuroscience Abstracts 1993; 19: 782
   Google Scholar
• Chase T.N., Geoffrey V., Gillespie M., et al. Structural and functional studies Gilles de la Tourette syndrome. Review Neurologie (Paris) 1986; 142: 851–859
   PubMed Web of Science ®Google Scholar
• Chesselett M.F., Graybiel A.M. Metenkephalin-like and dynorphin-like immunoreactivities of the basal ganglia of the cat. Life Science 1983; 33(Suppl 1)33–40
   Google Scholar
• Chiocca E.A., Martuza R.L. Neurosurgical therapy of the patient with obsessive-compulsive disorder. Obsessive Compulsive Disorders: Theory and Management, M.A. Jenike, L. Baer, W.E. Minichiello. Yearbook Medical Publishers, Chicago 1990
   Google Scholar
• Colino A., Halliwell J.V. Carbachol potentiates Q current and activates a calcium-dependent non-specific conductance in rat hippocampus in vitro. European Journal of Neuroscience 1993; 5: 1198–1209
   Google Scholar
• Conrad A.J., Abebe T., Austin R., Forsythe S., Scheibel A.B. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Archives of General Psychiatry 1991; 48: 413–417
   Google Scholar
• Delgado P.L., Charney D.S., Price L.H., Aghajanian G.K., Landis H., Heninger G.R. Serotonin function and the mechanisms of antidepressant action. Archives of General Psychiatry 1990; 47: 411–418
   PubMed Web of Science ®Google Scholar
• De Montigney C., Aghajanian G.K. Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science 1978; 202: 1303–1306
   PubMed Web of Science ®Google Scholar
• Devaud L.L., Hollingsworth E.B., Cooper B.R. Alterations in extracellular and tissue levels of biogenic amines in rat brain induced by the serotonin2 receptor antagonist, ritanserin. Journal of Neurochemistry 1992; 59: 1459–1466
   PubMedGoogle Scholar
• Early T.S., Relman E.M., Raichle M.E., Spitzmagel E.L. Left globus pallidus abnormality in newly medicated patients with schizophrenia. Proceedings of the National Academy of Science USA 1987; 84: 561–563
   PubMed Web of Science ®Google Scholar
• Eblen F., Graybiel A.M. Striosome/matrix affiliations of prefronto-striatal projections in the monkey. Society for Neuroscience Abstracts 1992; 18: 309
   Google Scholar
• Flaherty A.W., Graybiel A.M. Input-output organization of the sensorimotor striatum in the squirrel monkey. Journal of Neuroscience 1994; 14(2)599–610
   Google Scholar
• Foa E.B., Steketee G.S., Ozaroq B.J. Behavior therapy with obsessive-compulsives: from theory to treatment. Obsessive-Compulsive Disorder: Psychological and Pharmacological Treatment, M. Mavissakauan, S.M. Turner, L. Michelson. Plenum Press, New York 1985; 49–129
   Google Scholar
• Freud A. Obsessional neurosis: a summary of psychoanaltyic views as presented at the congress. International Journal of Psychoanalysis 1966; 47: 116–122
   PubMed Web of Science ®Google Scholar
• Fuller R.W., Wong D.T. Serotonin uptake and serotonin uptake inhibition. Annals of the NY Academy of Science 1990; 600: 68–80
   PubMed Web of Science ®Google Scholar
• Gerfen C.R., Herkenham M., Thibault J. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. Journal of Neuroscience 1987; 7(12)3915–3934
   PubMed Web of Science ®Google Scholar
• Gimenez-Amaya J.M., Graybiel A.M. Compartmental origins of the striatopallidal projection in the primate. Neuroscience 1990; 34(1)111–126
   Google Scholar
• Goodwin D.W., Guze S.B., Robins E. Follow-up studies in obsessional neurosis. Archives of General Psychiatry 1969; 20: 182–187
   PubMed Web of Science ®Google Scholar
• Graybiel A.M., Aosaki T., Flaherty A.W., Kimura M. The basal ganglia and adaptive motor control. Science 1994; 265: 1826–1831
   PubMed Web of Science ®Google Scholar
• Graybiel A.M., Ragsdale C. W., Jr. Biochemical Anatomy of the Striatum. Chemical Neuroanatomy, P.C. Emson. Raven Press, New York 1983; 427–504
   Google Scholar
• Graybiel A.M., Ragsdale C.W. Clumping of acetylcholinesterase activity in the developing striatum of the human fetus and young infant. Proceedings of the National Academy of Science 1980; 77: 1214–1218
   Google Scholar
• Groenewegen H.J., Vermeulen-Van der Zee E., Te Kortschot A., Witter M.P. Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. Neuroscience 1987; 23: 103–120
   PubMed Web of Science ®Google Scholar
• Grome J.J., Harper A.M. Local cerebral glucose utilization following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists. Journal of Neurochemistry 1986; 46: 117–124
   Google Scholar
• Groves P.M. A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Research Reviews 1983; 5: 109–132
   Web of Science ®Google Scholar
• Haber S.N., Watson S.J. The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain. Neuroscience 1985; 14: 1011–1024
   Google Scholar
• Hampson E., Kimura D. Sex differences and hormonal influences on cognitive function in humans. Behavioral Endocrinology, J.B. Becker, M. Breedlove, D. Crews. MIT Press, Cambridge 1992; 357–398
   Google Scholar
• Hatch J.P., Fisher J.G., Rugh J.D. Biofeedback: Studies in clinical efficacy. Plenum, New York 1987
   Google Scholar
• Heimer L., Zahm D.S., Churchill L., Kalivas P.W., Wohltmann C. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience 1991; 41: 89–125
   PubMed Web of Science ®Google Scholar
• Hollander E., Fay M., Cohen B., et al. Serotonergic and noradrenergic sensitivity in obsessive-compulsive disorder behavioral findings. American Journal of Psychiatry 1988; 145: 1015–1017
   PubMed Web of Science ®Google Scholar
• Hwang E., VanWoert M. Acute versus chronic effects of serotonin uptake blockers on potentiation of the serotonin syndrome. Commununications in Psychopharmacology 1980; 4: 161–176
   PubMedGoogle Scholar
• Insel T. Toward a neuroanatomy of obsessive-compulsive disorder. Archives of General Psychiatry 1992; 49: 739–744
   PubMed Web of Science ®Google Scholar
• Insel T.R., Murphy D.L., Cohen R.M., et al. Obsessive-compulsive disorder A double-blind trial of clomipramine and clorgyline. Archives of General Psychiatry 1983; 40: 605–612
   PubMed Web of Science ®Google Scholar
• Insel T.R., Winslow J.T. Neurobiology of obsessive compulsive disorder. Obsessive Compulsive Disorders: Theory and Management, M.A. Jenike, L. Baer, W.E. Minichiello. Yearbook Medical Publishers, Chicago 1990
   Google Scholar
• Jacobs B.L. Serotonin, motor activity and depression-related disorders. American Scientist 1994; 82: 456–463
   Web of Science ®Google Scholar
• Jacocks H.M., Cox B.M. Serotonin-stimulated release of [3H] dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-D-aspartic acid, glutamic acid and D-amphetamine. Journal of Pharmacology and Experimental Therapeutics 1992; 262: 356–364
   Google Scholar
• Jenike M.A. Approaches to the patient with treatment-refractory obsessive compulsive disorder. Journal of Clinical Psychiatry 1990; 51: 15–20, suppl
   PubMedGoogle Scholar
• Jenike M.A., Baer L., Ballantine H.T., et al. Cingulotomy for refractory obsessive-compulsive disorder a long-term follow-up of 33 patients. Archives of General Psychiatry 1991; 48: 548–555
   PubMed Web of Science ®Google Scholar
• Kelley A.E., Stinus L. Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with I-dopa. Behavioral Neuroscience 1985; 99: 531–545
   PubMed Web of Science ®Google Scholar
• Kidd E., Laporte A.M., Langlois X., Lombard M.C., Gozlan H., Hamon M. Differential localization and regulation of central 5-HT1A and 5-HT3 receptors. Serotonin CNS receptors and brain function, P.B. Bradley, S.L. Handley, S.J. Cooper, B.J. Key, N.M. Barnes, J.H. Coote. Pergamon Press, Oxford 1992
   Google Scholar
• Knapp S., Mandell A.J. Effects of lithium chloride on parameters of biosyndietic capacity for 5-hydroxytryptamine in rat brain. Journal of Pharmacological Experimental Therapeutics 1975; 193: 812–828
   PubMed Web of Science ®Google Scholar
• Krishnan K.R.R., McDonald W.M., Escalona P.R., Doraiswamy P.M., Na C., Husain M.M., Figiel G.S., Boyko O.B., Ellinwood E.H., Nemeroff C.B. Magnet resonance imaging of the caudate nuclei in depression. Archives of General Psychiatry 1992; 49: 553–557
   Google Scholar
• Lavoie B., Parent A. Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey. Journal of Comparative Neurology 1990; 299: 1–16
   PubMed Web of Science ®Google Scholar
• Leibenluft E., Fiero P.L., Rubinow D.R. Effects of the menstrual cycle on dependent variable in mood disorder research. Archives of General Psychiatry 1994; 51: 761–781
   PubMed Web of Science ®Google Scholar
• Luxenberg J.S., Swedo S.E., Flament M.F. Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative x-ray computed tomography. American Journal of Psychiatry 1988; 145: 1089
   PubMed Web of Science ®Google Scholar
• Mazziotta J.C., Phelps M.E. Positron emission tomography studies of the brain. Positron Emission Tomography and Autoradiography, M.E. Phelps, J.C. Mazziotta, H.R. Schelbert. Raven Press, New York 1986
   Google Scholar
• McDougle C.J., Goodman W.K., Price L.H., Delgado P.L., Krystal J.H., Charney D.S., Heninger G.R. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. American Journal of Psychiatry 1990; 147: 652–654
   PubMed Web of Science ®Google Scholar
• Middlemiss D.N., Bremer M.E., Smith S.M. A pharmacological analysis of the 5-HT receptor mediating inhibition of 5-HT release in the guinea pig frontal cortex. European Journal of Pharmacology 1988; 157: 101–107
   PubMed Web of Science ®Google Scholar
• Modell J.G., Mountz J.M., Curtis G.C., et al. Neurophysioiogical dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of Obsessive-Compulsive disorder. Journal of Neuropsychiatry 1989; 1: 27–36
   PubMedGoogle Scholar
• Mogenson G.J., Wu M. Disruption of food hoarding by injections of procaine into mediodorsal thalamus, GABA into subpallidal regions and halopendol into accumbens. Brain Research Bulletin 1988; 20: 247–251
   Google Scholar
• Morris B.J., Reiner S., Hollt V., Herz A. Regulation of striatal prodynorphin mRNA levels by the raphe-striatal pathway. Molecular Brain Research 1988; 4: 15–22
   Google Scholar
• Murphy D.L., Pigott T.A., Grady T.A., Broocks A., Altemus M. Neuropharmacological investigations of brain serotonin subsystem functions in obsessive-compulsive disorder. Advances in the Biosciences, P.B. Bradley, et al. Pergamon Press Ltd., Oxford 1992
   Google Scholar
• Nakazato T., Akiyama A. Effect of excitatory amino acids on dopamine and serotonin release in the rat striatum. Society for Neuroscience Abstracts 1992; 18: 1204
   Google Scholar
• Nauta W.J.H. Circuitous connections linking cerebral cortex, limbic system, and corpus striatum. The Limbic System: Functional Organization and Clinical Disorders, B.K. Doane, K.E. Livingston. Raven Press, New York 1986
   Google Scholar
• Nauta W.J.H. Reciprocal links of the corpus striatum with the cerebral cortex and limbic system: a common substrate for movement and thought?. Neurology and psychiatry. A meeting of minds. 1989, J. Muleller. Karger, New York
   Google Scholar
• Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Archives of General Psychiatry 1990; 47: 1023–1028
   PubMed Web of Science ®Google Scholar
• Palacios J.M., Waeber C., Mengod G., Pompeiano M. Molecular neuroanatomy of 5-HT receptors. Serotonin: Molecular Biology, Receptors and Funcational Effects, J.R. Fozard, P.R. Saxena. Birkhauser Verlag, Basel 1991
   Google Scholar
• Penney J.B., Young A.B. Speculations on the functional anatomy of basal ganglia disorders. Annual Review of Neuroscience 1983; 6: 73–94
   PubMed Web of Science ®Google Scholar
• Penney J.B., Young A.B. Striatal inhomogeneities and basal ganglia function. Movement Disorders 1986; 1: 3–15
   Google Scholar
• Pigott T.A., Zohar J., Hill J.L., Bernstein S.E., Grover G.N., Zohar-Kadouch R.C., Murphy D.L. Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chiorophenylpiperazine in patients with obsessive compulsive disorder. Biological Psychiatry 1991; 29: 418–426
   PubMed Web of Science ®Google Scholar
• Rappaport J., Wise S. Obsessive-compulsive disorder evidence for basal ganglia dysfunction. Psychopharmacological Bulletin 1988; 24: 380–388
   Google Scholar
• Rasmussen A., Eisen J.L. Clinical and epidemiological findings of significance to neuropharmacological trials in OCD. Psychopharmacological Bulletin 1988; 24: 466–470
   PubMedGoogle Scholar
• Rauch S.L., Jenike M.J., Alpert N.A., Baer L., Bretter H.C.R., Fischman A.J. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using 15 0-labeled co2 and positron emission tomography. Archives of General Psychiatry 1994; 51: 62–70
   PubMed Web of Science ®Google Scholar
• Reiner A., Albin R.L., Anderson K.D., D'Amato C.J., Penney J.B., Young A.B. Differential loss of striatal projection neurons in Huntington's Disease. Proceedings of the National Academy of Science 1988; 85: 5733–5737
   PubMed Web of Science ®Google Scholar
• Reynolds G.P., Pearson S.J. Brain GABA levels in asymptomatic Huntington's Disease. New England Journal of Medicine 1990; 323: 692
   Google Scholar
• Robertson M.M. The Gilles de la Tourette syndrome: the current status. British Journal of Psychiatry 1989; 154: 147
   PubMed Web of Science ®Google Scholar
• Schwarcz R., Shoulson I. Excitotoxins and Huntington's Disease. Animal Models of Dementia, J.T. Coyle. AR Liss, New York 1987
   Google Scholar
• Schwartz J.M., Martin K., Baxter L.R. Neuroimaging and cognitive-behavioral self-treatment in obsessive-compulsive disorder: practical and philosophical considerations. Obsessive-Compulsive Disorder: Recent Research, I. Hand, W. Gookman. Springer-Verlag, Berlin 1992
   Google Scholar
• Silver R.M., McKinley K., Smith E.A., Quearry B., Harati Y., Sternberg E.M., Heyes M.P. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome. Arthritis and Rheumatism 1992; 35: 733–741
   Google Scholar
• Sizer A.R., Long S.K., Roberts M.H.T. A modulatory function of 5-hydroxytryptamine in the central nervous system. Serotonin, CNS Receptors and Brain Function, P.B. Bradley, S.L. Handley, S.J. Cooper, B.J. Key, N.M. Barnes, J.H. Coote. Pergamon Press, Oxford 1992
   Google Scholar
• Sprouse J.S., Aghajanian G.K. Electrophysiological responses of serotonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1987; 1: 3–9
   PubMed Web of Science ®Google Scholar
• Suddath R.L., Christison M.D., Torrey E.F., Cassanova M., Weinberger D.R. Anatomic abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine 1990; 322: 789–794
   PubMed Web of Science ®Google Scholar
• Swedo S.E., Pietrini P., Leonard H.L., et al. Cerebral glucose metabolism in childhood-onset obsessive compulsive disorder. Archives of General Psychiatry 1992; 49: 690–694
   PubMed Web of Science ®Google Scholar
• Swedo S.E., Rapoport J.L., Cheslow D.L., Leonard H.L., Ayoub E.M., Hosier D.M., Wald E.R. High prevalence of obsessive-compulsive symptoms in patients with Sydenham's chorea. American Journal of Psychiatry 1989; 146: 246–249
   PubMed Web of Science ®Google Scholar
• Swerdlow N.R., Caine S.B., Braff D.L., Geyer M.A. Neural substrates of sensorimotor gating of the startle reflex: A review of recent findings and their implications. Journal of Psychopharmacology 1992; 6: 176–190
   PubMed Web of Science ®Google Scholar
• Swerdlow N.R., Benbow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensorimotor gating in patients with Obsessive Compulsive Disorder (OCD). Biological Psychiatry 1993; 33: 298–301
   PubMed Web of Science ®Google Scholar
• Swerdlow N.R., Hartman P., Auerbach P.P. Effects of gender and laterality on sensorimotor gating of the human startle reflex. Biological Psychiatry 1994; 35: 616
   Google Scholar
• Swerdlow N.R., Koob G.F. Dopamine, schizophrenia, mania and depression: Toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behavioral Brain Science 1987; 10: 197–245
   Web of Science ®Google Scholar
• Thoren P., Asberg M., Cronholm B., et al. Clomipramine treatment of obsessive-compulsive disorder. I: a controlled clinical trial. Archives of General Psychiatry 1980a; 37: 1281–1285
   PubMed Web of Science ®Google Scholar
• Thoren P., Asberg M., Bertilsson L., et al. Clomipramine treatment of obsessive-compulsive disorder. II: biochemical aspects. Archives of General Psychiatry 1980b; 37: 1286–1294
   Web of Science ®Google Scholar
• Thorpe S.J., Rolls E.T., Maddison S. The orbitofrontal cortex: Neuronal activity in the behaving monkey. Experimental Brain Research 1983; 49: 93–115
   PubMed Web of Science ®Google Scholar
• Tollefson G.D., Rampey A.H., Potvin J.H., et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Archives of General Psychiatry 1994; 51: 559–567
   PubMed Web of Science ®Google Scholar
• Waeber C., Palacios J.M. Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: a quantitative in vitro autoradiography study. Neuroscience 1989; 32: 337–347
   Google Scholar
• Waeber C., Palacios J.M. 5-HT1C, 5-HT1D and 5-HT2 receptors in mammalian brain: Multiple affinity states with a different regional distribution. Serotonin: Molecular Biology, Receptors and Functional Effects, J.R. Fozard, P.R. Saxena. Verlag, Basel 1991
   Google Scholar
• Waeber C., Zhang L., Palacios J.M. 5-HTid receptors in the guinea-pig brain: pre- and postsynaptic localizations in the striato-nigral pathway. Brain Research 1989; 528: 197–206
   Google Scholar
• Wang R.Y., Ashby C. R., Jr., Edwards E. Characterization of 5-HT3-like receptors in the rat cortex: electrophysical and biochemical studies. Serotonin: Molecular Biology, Receptors and Functional Effects, J.R. Fozard, P.R. Saxena. Birkhauser Verlag, Basel 1991
   Google Scholar
• Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry 1987; 44: 660–669
   PubMed Web of Science ®Google Scholar
• Wilkinson L.O., Averbach S.B., Jacobs B.L. Extracellular serotonin levels change with behavioral state but not with pyrogen-induced hyperthermia. Journal of Neuroscience 1991; 11: 2732–2741
   PubMed Web of Science ®Google Scholar
• Wong D., Wagner H., Tune L., Dannals R., Pearlson G., Links J., Tamminga C., Broussolle E., Ravert H., Wilson A., Toung J., Malat J., Williams J., O'Tuama L., Snyder S., Kuhar M., Gjedde A. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234: 1558–1563
   PubMed Web of Science ®Google Scholar
• Zohar J., Insel T.R., Zohr-Kadouch R.C., Hill J.L., Murphy D.L. Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment. Archives of General Psychiatry 1988; 45: 167–172
   PubMed Web of Science ®Google Scholar
• Zohar J., Mueller E.A., Insel T.R., Zohar-Kadouch R.C., Murphy D.L. Serotonergic responsivity in obsessive-compulsive disorder: Comparison of patients and healthy controls. Archives of General Psychiatry 1987; 44: 946–951
   PubMed Web of Science ®Google Scholar